What is Rigel Pharmaceuticals's net income?

Rigel Pharmaceuticals (RIGL) reported net income of $8.65M in Q1 2026.

How has Rigel Pharmaceuticals's net income changed year-over-year?

Rigel Pharmaceuticals's net income decreased by 24.4% year-over-year, from $11.45M to $8.65M.

What is the long-term trend for Rigel Pharmaceuticals's net income?

Over 4 years (2021 to 2025), Rigel Pharmaceuticals's net income has grown at a 112.8% compound annual growth rate (CAGR), from -$17.91M to $367.02M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Rigel Pharmaceuticals RIGL Net Income

Net Income at other companies

AmgenAMGN

$1.82B+5.1%

Agios PharmaceuticalsAGIO

-$99.11M-11.0%

Nuvation BioNUVB

$5.4M+110%

Zevra Therapeutics, Inc.ZVRA

$37.89M+1,323%

Eton Pharmaceuticals, Inc.ETON

$1.55M+199%

Theravance BiopharmaTBPH

-$4.93M+63.7%

Segments

By segment

See full

Single reportable segment$8.65M—

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's net income?: Rigel Pharmaceuticals (RIGL) reported net income of $8.65M in Q1 2026.
How has Rigel Pharmaceuticals's net income changed year-over-year?: Rigel Pharmaceuticals's net income decreased by 24.4% year-over-year, from $11.45M to $8.65M.
What is the long-term trend for Rigel Pharmaceuticals's net income?: Over 4 years (2021 to 2025), Rigel Pharmaceuticals's net income has grown at a 112.8% compound annual growth rate (CAGR), from -$17.91M to $367.02M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.